How to evaluate healthcare systems in primary angioplasty
暂无分享,去创建一个
[1] J. Messenger,et al. Door-to-Balloon Time and Mortality Among Patients Undergoing Primary PCI , 2014 .
[2] John S Rumsfeld,et al. Door-to-balloon time and mortality among patients undergoing primary PCI. , 2013, The New England journal of medicine.
[3] T. Lash,et al. Persistent geographical disparities in the use of primary percutaneous coronary intervention in 120 European regions: exploring the variation. , 2013, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[4] M. D. Belder. Interventional management of acute coronary syndromes: applying the lessons of ST-elevation services to non-ST-elevation myocardial infarction , 2012 .
[5] D. Atar,et al. ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation , 2013 .
[6] J. Hartikainen,et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries , 2009, European heart journal.
[7] C. Catalano,et al. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance. , 2009, Journal of the American College of Cardiology.
[8] Harlan M Krumholz,et al. ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-El , 2006, Journal of the American College of Cardiology.